2020
DOI: 10.1111/ijlh.13412
|View full text |Cite
|
Sign up to set email alerts
|

COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces

Abstract: In December 2019, a new type of coronavirus was detected for the first time in Wuhan, Hubei Province, China. According to the reported data, the emerging coronavirus has spread worldwide, infecting more than fifty‐seven million individuals, leading to more than one million deaths. The current study aimed to review and discuss the hematological findings of COVID‐19. Laboratory changes and hematologic abnormalities have been reported repeatedly in COVID‐19 patients. WBC count and peripheral blood lymphocytes are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
34
1
15

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 60 publications
(54 citation statements)
references
References 58 publications
(91 reference statements)
2
34
1
15
Order By: Relevance
“…These factors were not particularly included in our prediction model, although the “hemato” rubric on our risk matrix considers all abnormalities discovered in each patient evaluated. Here, a systematic review carried by Shahri et al [ 20 ] discovered that leukopenia seems to be directly proportional correlated to COVID-19 disease severity, while lymphopenia can be used as a prognostic prediction factor. Another systematic review conducted by Slomka et al [ 21 ] proves that D-dimer levels are markedly increased in patients with severe COVID-19 infection.…”
Section: Discussionmentioning
confidence: 99%
“…These factors were not particularly included in our prediction model, although the “hemato” rubric on our risk matrix considers all abnormalities discovered in each patient evaluated. Here, a systematic review carried by Shahri et al [ 20 ] discovered that leukopenia seems to be directly proportional correlated to COVID-19 disease severity, while lymphopenia can be used as a prognostic prediction factor. Another systematic review conducted by Slomka et al [ 21 ] proves that D-dimer levels are markedly increased in patients with severe COVID-19 infection.…”
Section: Discussionmentioning
confidence: 99%
“…2,3 Interestingly, significant differences in morphology and function of monocytes have been recently observed between COVID-19 patients and healthy individuals. 4 Therefore, in this article, we aim to provide a pooled analysis of studies that have addressed the potential clinical utility of MDW for predicting SARS-CoV-2 infection at hospital admission.…”
mentioning
confidence: 99%
“…Recently, Y. Liu et al, 2020d;Shahri et al, 2021;Yang et al, 2020b have found that thrombocytopenia could increase the mortality risk among COVID-19 patients. It was also noticed that the daily count of recovery cases exceeded the con rmed cases after mid-September, 2020 and this parallel pattern continued up to the end of January, 2021 when the AT was continuously decreasing.…”
Section: Resultsmentioning
confidence: 99%